TSS
INDP icon

Two Sigma Securities’s Indaptus Therapeutics INDP Stock Holding History

Two Sigma Securities’s Portfolio INDP Stock Details INDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-594
Closed -$14K – 1808
2024
Q4 		$14K Buy
+594
New +$18.9K ﹤0.01% 1381
2021
Q2 		– Sell
-102
Closed -$50K – 1590
2021
Q1 		$50K Buy
+102
New +$53.5K ﹤0.01% 732
2020
Q3 		– Sell
-24
Closed -$15K – 1473
2020
Q2 		$15K Buy
+24
New +$14.8K ﹤0.01% 1298
2020
Q1 		– Sell
-6
Closed -$7K – 1812
2019
Q4 		$7K Buy
+6
New +$8.28K ﹤0.01% 2278

Other funds holding INDP

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IHL
Investment House LLC Redondo Beach, California $2.21B AUM 39.6% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SAM
Strategy Asset Managers Pasadena, California $670M AUM 34.04% 1-Year Est. Return
PVI
Pine Valley Investments Marlton, New Jersey $2.53B AUM 36.18% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
VCM
Vivaldi Capital Management Chicago, Illinois $723M AUM 30.89% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return

Two Sigma Securities's INDP Position: Q1 2025 in Review

Two Sigma Securities sold out of Indaptus Therapeutics (INDP) in Q1 2025, closing a stake of 594 shares — an estimated $14K sold.

Two Sigma Securities first reported a position in INDP in Q4 2019 and held it in 4 quarters. The position peaked at $50K in Q1 2021. 17 funds tracked by Wall St. Rank hold INDP as of Q1 2025.

  • Two Sigma Securities reported no remaining Indaptus Therapeutics position as of Q1 2025 after selling out during the quarter.
  • Two Sigma Securities sold 594 Indaptus Therapeutics shares in Q1 2025, an estimated $14K.
  • Two Sigma Securities first reported a position in Indaptus Therapeutics in Q4 2019 and held it in 4 quarters.
  • Two Sigma Securities's Indaptus Therapeutics position peaked at $50K in Q1 2021.
  • 17 funds tracked by Wall St. Rank held Indaptus Therapeutics as of Q1 2025.

Based on Two Sigma Securities's 13F filing for Q1 2025, filed 15 May 2025.